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Abstract. Excessive alcohol consumption is associated with increased morbidity and mortality as well as with labour and
traffic accidents. However, current evidence suggests beneficial effects of moderate drinking on cardiovascular events including
coronary heart disease, ischaemic stroke, peripheral arterial disease and congestive heart failure. The underlying mechanisms
to explain these protective effects against coronary heart disease include an increase in high-density lipoprotein cholesterol and
an increase in insulin sensitivity, and a decrease in platelet aggregation and circulating concentrations of fibrinogen. However,
there are discrepancies regarding the specific effects of different types of beverages on the cardiovascular system, and also
whether the possible protective effects of alcoholic beverages are due to their alcohol component (ethanol) or non-alcoholic
products containing, mainly polyphenols. Recent randomised clinical trials have shown that wine, a polyphenol-rich alcoholic
beverage, provides higher antioxidant and anti-inflammatory effects than some spirits such as gin, a polyphenol-free alcoholic
beverage. In addition, dealcoholized red wine decreases blood pressure through a nitric oxide mediated mechanism, suggesting
a protective effect of polyphenols on vascular function. Other studies performed in women have observed that daily doses of
15–20 g of alcohol as red wine are sufficient to elicit protective effects similar to those observed in men who consumed higher
doses of wine. In conclusion, moderate consumption of wine exerts a protective effect on biomarkers related to the progression
and development of atherosclerosis due to its alcoholic (ethanol) and non-alcoholic (polyphenols) content. Women are more
sensitive to the beneficial effects of wine.
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1. Introduction
The healthy effects of wine are known from ancient
times. In fact, wine has been used in old medicine
as an antiseptic, a painkiller and as a treatment for
several dermatological and digestive disorders [46].
In addition, wine has been closely associated with
healthy diets, particularly in Mediterranean countries
[49] and many people have attributed great benefits to
wine consumption with no scientific basis. The first
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modern evidence of a scientific link between alcohol
consumption and cardiovascular disease was made in
the early part of the last century, when it was observed
in necropsy studies that individuals that died from alco-
holic cirrhosis had cleaner arteries than they ought
to according to their age and lifestyle habits, sug-
gesting that alcohol could exert a protective effect
against atherosclerosis. Many years later, in the 1970s,
several researchers started to scientifically study the
relationship between alcohol consumption and over-
all mortality or other hard end-points such as coronary
heart disease [12], stroke [34], peripheral arterial dis-
ease [35] and heart failure [16]. The overall conclusion
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of these studies is that people consuming one to two
standard drinks per day showed a lower cardiovascu-
lar event rate than subjects abstaining from alcohol
and those with high alcohol intake [47], a relationship
described as J-shaped (or U-shaped) curve [11, 56].
Most of these epidemiological studies correlating
moderate alcohol intake with protector effects on
the cardiovascular system did not take into account
the type of beverage consumed. However, after the
description of the French Paradox 20 years ago, part
of the research was focused on the protective effects of
moderate wine intake compared to the effects of other
alcoholic beverages, mainly beer and spirits. Based on
epidemiological data, the term “French Paradox” was
used to describe the low incidence of cardiovascular
disease and the mortality of French population despite
their high intake of dietary saturated fats. This para-
dox has been attributed to moderate wine consumption
by the French population, but it was not related to
alcohol (ethanol) contained in wine, since plasma high-
density lipoprotein cholesterol (HDLc) concentrations
were similar to those observed in other countries with
a higher prevalence of coronary heart disease that con-
sume mainly other alcoholic beverages [44]. From the
beginning, the French Paradox received several criti-
cisms [6, 32], opened an interesting debate as to which
type of alcoholic beverage is more cardioprotective
than the others and triggered several studies on the
effects of the different components of red wine, mainly
alcohol and polyphenols on the health, but especially
on cardiovascular system. However, the debate con-
tinues; the key question related to alcoholic beverages
continues to be whether the beneficial effects of mod-
erate consumption of alcoholic beverages is due to
ethanol, to their polyphenolic content, or both.
2. Negative effects of alcoholic beverages
It is always important to remember that exces-
sive alcohol intake induces the appearance of several
chronic diseases including chronic alcoholism, liver
disease, pancreatitis, different types of encephalopathy
and neurodegenerative diseases, peripheral neuropa-
thy, myopathy and also cardiomyopathy (Table 1). In
fact, chronic alcohol intake gives rise to acute and
chronic effects on the cardiovascular system. Among
the acute effects, the most frequent action of ethanol
on the heart is to induce cardiac arrhythmias. Clini-
cians have long recognized the temporal association
of binge drinking and the onset of atrial fibrillation,
especially during weekends, a disease known as the
“holiday heart syndrome”. In addition, high alcohol
intake may provoke ventricular tachyarrhythmias and
sudden death. A quarter of the young or middle-aged
adult sudden deaths are related to an overdose of alco-
hol, especially in those who suffer from a subclinical
cardiomyopathy [24]. On the other hand, the main
chronic effects of maintained high ethanol intake on
the cardiovascular system are dilated cardiomyopa-
thy and arterial hypertension. The development of an
alcoholic cardiomyopathy requires the consumption of
high amounts of ethanol during more than 10 years. In
our experience, the first clinical features of alcoholics
with dilated cardiomyopathy is usually observed when
the subject have drunk a total lifetime dose of ethanol
higher than 20 kg of ethanol/kg of body weight [57].
High alcohol intake also produces an increase of blood
pressure, whereas alcohol abstinence reduces systolic
and diastolic blood pressures to normal or near normal
values [18]. In the Framingham study the prevalence
of hypertension was double in people who consumed
great amounts of alcohol compared with the moderate
consumers. However, not all who have consumed high
amounts of alcohol develop dilated cardiomyopathy.
Great individual vulnerability has been reported in the
toxic effects of alcohol. Thus, women and relatives of
patients with alcoholic cardiomyopathy have a higher
prevalence of cardiac dysfunction compared to men or
non relatives who have consumed the same amounts
of alcohol [58]. This individual vulnerability to the
organic injuries by alcohol has been attributed to some
genetic characteristics of the subjects. As an example,
a close relationship has been observed between alco-
holic cardiomyopathy and polymorphism of the gene
of the angiotensin-converting enzyme [21].
3. Positive effects of moderate wine
consumption on cardiovascular system
On the other hand, several studies have shown that
moderate alcohol consumption mainly in the form
of wine could have beneficial effects (protective) on
health (Table 1). Up to now, the cardioprotective effect
of moderate consumption of wine or alcohol has been
documented in several ecological, epidemiological,
necropsy, case-control and cohort studies performed
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Table 1
Positive (moderate intake) and negative effects (excessive intake) of
alcoholic beverages
Effects of the consumption of alcoholic drinks
Negative Positive
• Alcoholic dependence Reduction of:
• Liver cirrhosis • Global mortality
• Acute and chronic
pancreatitis
• Cardiovascular disease
• Dilated cardiomyopathy • Cancer
• Encephalopathies • Alzheimer disease
• Polyneuritis • Diabetes mellitus
• Myopathy • Renal and vesicular lithiasis
• Fetal alcoholic syndrome • Rheumatoid arthritis,
• Accidents and violence . . .
in countries such as France, Denmark, Yugoslavia, the
United States, China and New Zealand [59]. In eco-
logical studies, all but one study reported a significant
inverse correlation between wine consumption and
mortality due to coronary heart disease [53]. Prospec-
tive cohort studies are the most reliable type of study in
this respect, because there is a link between exposure
and outcome at the individual level and the prob-
lem of confounding may be overcome by adjustment
techniques. In a great number of epidemiologic stud-
ies, the effects of the three main types of alcoholic
drinks (wine, beer and distilled drinks) on the car-
diovascular system have been analysed. In the latest
meta-analysis of Constanzo et al. [12], the authors
analysed the effects of the consumption of wine on car-
diovascular risk separately from beer and spirits and
after the joint analysis of 16 studies they confirmed
a J-shape relationship between wine intake and vas-
cular risk, with a maximal protection of 31% (95%
confidence interval (CI): 19–43%) at 21 g/d of alco-
hol. Interestingly, the results of the studies differed
depending on the continent where were performed.
Thus, in many epidemiological studies from United
States, especially those based on the registries of the
Nurse’s Health Study [17] or the Health Profession-
als Follow-up Study [33] no differences were found
between the protective effects of the moderate con-
sumption of the different types of drink consumed,
whereas in some European studies such as the Copen-
hagen City Heart Study [22] or the one carried out in
the east of France [44] found a high significant relation
between low or moderate consumption of wine and a
lower mortality by cardiovascular disease. Results of
more recent cohort studies have confirmed that, among
patients with established heart disease or at high-risk
of developing this disease, moderate consumption of
wine is associated with a lower incidence of cardiovas-
cular events and total mortality as compared with no
drinkers [24, 31, 37, 48]. Part of these discrepancies
may be due to different confounding factors difficult
to strictly control in even prospective cohort studies.
Thus, the pattern of drinking is absolutely different
in Mediterranean countries form Anglo-Saxon coun-
tries [48] and, more important, wine drinkers usually
consume healthy foods compared to beer and liquor
drinkers [25].
The best way to solve these discrepancies is to per-
form randomized clinical trials that allow an optimal
control of these confounding factors. In addition, the
scientific evidence of these trials is higher than that
of the cohort trials. However, interventional clinical
trials regarding alcoholic beverages must contemplate
several ethical considerations and the length of these
studies is limited because of the personal difficulties
to accomplish interventions, thus, well-designed ran-
domized clinical trials which evaluate hard end-points
as final variables are warranted. In the meanwhile,
randomized clinical trials that evaluate intermediate
markers of cardiovascular risk allow us to assess the
differences in effects of the different alcoholic bever-
ages on the cardiovascular system, always within the
context of moderate intake.
4. Insulin sensitivity and type 2 diabetes
mellitus
Diabetes mellitus is one the main risk factors of
cardiovascular disease. Two meta-analyses of 15 and
20 cohort studies [3, 40] pointed out that moderate
drinkers show a lower incidence of type 2 diabetes
mellitus than lifetime abstainers or excessive con-
sumers, with an apparent J-shape association. This
effect seemed to be independent of the type of alcoholic
beverage consumed. However, in other prospective
studies, the inverse association between moderate alco-
hol consumption and lower diabetes risk was most
apparent in women who reported to drink preferen-
tially wine or beer than in those who consumed liquor
[60]. This beneficial effect has been related to improved
insulin sensitivity enhancing insulin secretion, pancre-
atic-cell survival and/or glucose uptake by peripheral
tissues, among others.
However, the results of clinical studies examining
the effects of moderate alcohol intake and the different
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types of alcoholic beverages have been inconsistent.
Some studies have reported no significant changes in
insulin sensitivity after intake of wine or spirits [4,
36, 51], whereas others have reported an improvement
with any beverage [14, 27]. In this respect, a recent
randomized trial performed in high-risk men, moderate
dealcoholized red wine and red wine, but not gin signif-
icantly improved insulin sensitivity [9], suggesting that
polyphenols may play a key role in the prevention of
diabetes. In fact, intervention studies with grapes and
grape seed extract improved glycemic status in type
2 diabetic patients [38, 62]. Thus, moderate alcohol
intake, mainly in the form of wine, helps to main-
tain or even improve insulin sensitivity. However, more
studies are warranted on this issue.
5. Lipid effects
Increase of plasma HDL-cholesterol is the most
well-described effect of moderate alcohol consump-
tion, and until recently, this was considered as the main
protector effect of alcohol intake on cardiovascular sys-
tem. This effect is observed after the consumption of
any alcoholic beverage in a dose-dependent manner,
and, accordingly, it is considered to be due to ethanol
itself [5]. Ethanol also seems to increase ApoA-I and II
[9, 20]. The effects on triglycerides, LDL-cholesterol
and lipoprotein (a) are still under debate. There are
several limitations analyzing these effects since the dif-
ferent studies performed have different lengths, some
variables analyzed have a longer half-life time than
that analyzed, especially in cross-sectional studies, and
differences in the characteristics of the participants,
such as age, sex, and cardiovascular risk factors, limit
the comparison between studies. However, despite of
these limitations, a J-shape increase of presenting high
triglycerides was observed among 2014 hypertensive
men, with the lowest plasma triglyceride concentra-
tions being found in moderate alcohol consumers [41].
LDL-concentrations do not change after moderate
alcohol consumption [5]. In respect to lipoprotein (a),
a meta-analysis [5] pointed out that moderate alcohol
intake has no effect on this variable, but in two clinical
trials performed in healthy men [20] and high-risk sub-
jects [9] adjusted mean lipoprotein (a) was significantly
reduced after red wine, but not after gin interventions.
Thus, given the paucity of effective therapy for ele-
vated lipoprotein (a), the potential lowering efficacy of
ethanol and/or polyphenols deserves further research.
However, since grapes, grape juice and grape extracts
positively modify cholesterol homeostasis [26, 49] and
red wine is more effective than white wine changing
lipid profile, wine polyphenols also play a role on lipid
changes observed in moderate drinkers [23].
6. Effects on blood pressure and endothelial
function
Although the negative effects of heavy and binge
alcohol drinking on blood pressure are well known,
the effects of moderate alcohol consumption are con-
troversial, since some studies have observed a linear
trend and others a non-linear or even a J-shaped asso-
ciation [2, 10]. A meta-analysis has pointed out that
alcohol consumption increases the risk of hypertension
in dose-dependent manner [54] and reduction of alco-
hol consumption leads to a decrease in blood pressure
also in a dose-response relationship [61]. However,
moderate alcohol intake, especially in the form of red
wine, seems to reduce blood pressure. In fact, in vitro
and experimental studies have shown a blood pres-
sure lowering effect and an enhancement of endothelial
nitric oxide production [15]. However these results are
difficult to extrapolate to humans since the amount of
polyphenols from red wine used in these studies is
usually higher than that achieved in plasma through
moderate wine intake. In a recent 4-week intervention
cross-over clinical trial, moderate doses of dealco-
holized red wine decreased systolic and diastolic blood
pressure while increasing plasma NO concentration.
Red wine tended to have similar effects to those of deal-
coholized red wine, but the changes did not achieve
statistical significance, and gin had no effect. Thus,
these blood pressure-lowering effects and NO-raising
effects should be attributed to red wine polyphenols
and not to alcohol [7].
On the other hand, the effects of moderate alcohol
intake on endothelial function remain controversial.
In a multiethnic cross-over study, those subjects who
drank between >1 drink/month and 2 drinks/day
showed a higher flow-mediated dilation (FMD) than
non drinkers or those who drank more than 2
drinks/day, independent of the type of alcoholic
beverage consumed [52]. However, in randomized
intervention trials, 30 g of alcohol as red wine showed
significant beneficial effects on endothelial function
1–4 h after ingestion, while beer and white wine had
a borderline effect and whiskey exerted no effect [55].
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In other studies either red wine and dealcoholized
red wine decreased plasma endothelin-1 concentration
[39]. Thus, it seems that red wine polyphenols exert a
beneficial effect on endothelial function but this effect
do not persist >4 h.
7. Thrombosis and ﬁbrinolysis system
Heavy alcohol intake has been associated with
lower fibrinolytic capacity, a more procoagulant state
and a higher blood viscosity, whereas moderate alco-
hol consumption is consistently associated with a
decreased procoagulant state and blood viscosity, as
well as a higher fibrinolytic capacity. In a meta-
analysis, consumption of less than 12 g of ethanol/day
was significantly associated with a decreased relative
risk of total stroke [45]. In addition, in population
studies, alcohol consumption was associated with a
reduced risk of venous thrombosis and lower fibrino-
gen levels [42]. In randomized clinical trials, plasma
fibrinogen levels decreased after red wine and gin
intake, suggesting that this effect is due to ethanol
contained in alcoholic beverages [20]. Other posi-
tive effects of moderate alcohol intake on hemostatic
system include inhibition of platelet aggregation and
reduction of concentration of tissue factor and factors
VII, VIII and VIII-von Willebrand. Wine, by itself, also
increases plasminogen activator-1/plasminogen acti-
vator (PAI-1/tPA) ratio. Therefore, the anticoagulant
effect of moderate alcohol consumption seems to be
effective in both healthy subjects and patients with a
pro-coagulant profile. However, a linear relationship
between increased alcohol consumption and risk of
hemorrhagic stroke was also observed.
8. Mechanisms of the cardioprotective effect of
moderate wine intake
The beneficial effects of moderate wine intake on the
cardiovascular system have been related to their action
on oxidative status and inflammation of the arterial
wall.
8.1. Oxidative status
While alcohol itself is known to induce oxidative
stress, several in vitro studies regarding polyphenols
from wine, beer, and vegetables have shown that these
compounds exert an antioxidant effect. Accordingly,
it seems that there are a counteracting effect between
polyphenols and alcohol. Several clinical trials have
shown that red wine increases plasma antioxidant
capacity, suppresses reactive oxygen species genera-
tion, reduces plasma malondialdehide, prolongs lag
phase time of low-density lipoprotein (LDL) parti-
cles and decreases oxidative DNA damage [20]. By
contrast, ethanol decreases antioxidant and increases
lipoperoxidation serum parameters [1]. In addition, a
postprandial reduction of oxidative stress has also been
observed after red wine consumption [13], an interest-
ing effect that help to promote the consumption of wine
always with meals.
8.2. Inﬂammation
Atherosclerosis is considered a low-grade inflam-
matory disease. In a meta-analysis [5], the association
between alcohol intake and plasma concentration
of different inflammatory biomarkers related to
atherosclerosis, such as C-reactive protein (CRP),
interleukin 6 (IL-6) and tumour necrosis factor-
(TNF-) was not significant. However, when the type
of alcoholic beverage was considered, the results dif-
fered. In a 4-week randomized cross-over trial, red
wine and gin decreased IL-1, but only red wine but not
gin diminished plasma CRP in healthy subjects [19],
explaining why CRP is not affected when only alcohol
is considered. In addition, the effects are not the same
in high-risk vascular subjects, since alcohol (red wine
and gin) increased the anti-inflammatory IL-10 and
decreased IL-16, and red wine but not gin decreased
plasma IL-6 concentration [8].
Cell adhesion molecules and cytokines are other
inflammatory biomarkers related to atherosclerosis
since these molecules participate in the recruitment of
circulating leukocytes to the vascular endothelium and
further migration to subendothelial spaces, initiating
the atherosclerotic process. In healthy volunteers [19]
significant reductions of vascular cellular adhesion
molecule-1 (VCAM-1), intercellular CAM-1 (ICAM-
1), very late antigen-4 (VLA-4) lymphocyte expression
and lymphocyte function associated antigen-1 (LFA-
1), macrophage-1 antigen (Mac-1), VLA-4 and
monocyte chemoprotein-1 (MCP-1) monocyte expres-
sion were observed after red wine, but not after gin
intake. Again, the effects in high-risk subjects were
different but protective [8].
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Table 2
Mechanisms of the positive and negative effects of the moderate consumption of alcoholic drinks with (wine) and without (gin)
polyphenols [15]
Effects of Alcoholic Drinks without Polyphenols (GIN)
Positive Negative
On lipoproteins On plasmatic homocysteine
Increase in HDL-cholesterol Increase in total homocysteine
Reduction of lipoprotein a Reduction in folic acid
Reduction of the oxidation of LDL-cholesterol
On the metabolism of the glucose
Increase in the sensitivity to the insulin
On the inﬂammation markers
Reduction of C-reactive protein
Reduction of ICAM-1 and VCAM-1
Reduction of interleukin-1
Reduction of fibrinogen
On haemostasis
Reduction of platelet aggregation
Reduction of the tissue factor
Reduction of factor VII, VIII and VIII-von Willebrand
Effects of Alcoholic Beverages with Polyphenols (WINE)
Positive Negative
On lipoproteins None
Increase in HDL-cholesterol
Reduction of lipoprotein a
Reduction of the oxidation of LDL-cholesterol
On the metabolism of the glucose
Increase in sensitivity to insulin
On the inﬂammation markers
Reduction of reactive protein C
Reduction of ICAM-1 and VCAM-1
Reduction of interleukin-1
Reduction of molecules of adhesion LFA-1, Mac-1, VLA-4 and chemokine
MCP-1 in circulating monoliths
Inhibition of nuclear factor κB
Reduction of fibrinogen
On the hemostasis
Reduction of platelet aggregation
Reduction of the tissue factor
Reduction of factor VII, VIII and VIII-vW
Increase in the tissue factor of plasminogen
Increase in the activity of PAI-1
On the vascular function
Increase in the coronary vasodilatation induced by adenosine.
9. Summary
Although heavy or binge alcohol consumption leads
to an increase in the risk of all-causes death and makes
up a enormous social and economical problem that
must be addressed, moderate alcohol consumption,
especially in the form of wine, has cardioprotec-
tive effects through different mechanisms. Moderate
wine consumption improves glucose metabolism, lipid
profile, endothelial function and coagulation and
platelet function throughout their anti-oxidant and anti-
inflammatory effects (Table 2). All these protective
effects explain the reduction in overall and cardiovas-
cular mortality of moderate wine drinkers reported in
some epidemiological studies. Nevertheless, although
they are hard to carry out and need careful ethical con-
siderations, more long-term clinical trials are needed to
elucidate whether other mechanisms may be involved
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in these protective effects and which type of alcoholic
beverage is more cardioprotective with the highest
level of scientific evidence.
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